FibroBiologics, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/07/2025 | 1.79 M | $3.57 M | 1.69% | 5.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 604,927 | $1.21 M | 0.86% | 1.80% |
| CASCADE FINANCIAL PARTNERS, LLC | 02/07/2025 | 282,601 | $565,202 | -6.61% | 0.84% |
| NORTHERN TRUST CORP | 02/14/2025 | 215,413 | $430,826 | 2.35% | 0.64% |
| 02/13/2025 | 110,100 | $220,200 | 0.00% | 0.33% | |
| REQUISITE CAPITAL MANAGEMENT, LLC | 01/21/2025 | 109,713 | $219,426 | 0.00% | 0.33% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 89,852 | $179,704 | -7.68% | 0.27% |
| AMERICAN INSTITUTE FOR ADVANCED INVESTMENT MANAGEMENT, LLP | 01/23/2025 | 88,206 | $176,412 | 0.00% | 0.26% |
| CERITY PARTNERS LLC | 02/13/2025 | 78,101 | $156,202 | 49.91% | 0.23% |
| MORGAN STANLEY | 02/14/2025 | 57,389 | $114,778 | -18.60% | 0.17% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 02/12/2025 | 40,404 | $80,808 | 100.00% | 0.12% |
| RMR WEALTH BUILDERS | 01/14/2025 | 38,360 | $76,720 | 0.26% | 0.11% |
| CONCURRENT INVESTMENT ADVISORS, LLC | 02/03/2025 | 35,283 | $70,566 | 0.00% | 0.11% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 34,540 | $69,080 | 0.00% | 0.10% |
| ERN FINANCIAL, LLC | 01/14/2025 | 31,819 | $63,638 | 0.00% | 0.09% |
| NEWEDGE ADVISORS, LLC | 02/13/2025 | 25,906 | $51,812 | 0.00% | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 25,000 | $50,000 | 0.00% | 0.07% |
| ETHOS FINANCIAL GROUP, LLC | 02/06/2025 | 24,424 | $48,848 | -4.05% | 0.07% |
| CITIGROUP INC | 02/12/2025 | 21,894 | $43,788 | 9.25% | 0.07% |
| RHUMBLINE ADVISERS | 01/30/2025 | 21,572 | $43,144 | 1.67% | 0.06% |
| SAXON INTERESTS, INC. | 01/15/2025 | 21,214 | $42,428 | 0.00% | 0.06% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 18,642 | $37,284 | 100.00% | 0.06% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 15,925 | $31,850 | 14.44% | 0.05% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 14,862 | $30,000 | 100.00% | 0.04% |
| FLAHARTY ASSET MANAGEMENT, LLC | 02/05/2025 | 14,702 | $29,404 | 0.00% | 0.04% |
| CAHABA WEALTH MANAGEMENT, INC. | 02/13/2025 | 14,702 | $29,404 | 0.00% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 13,596 | $27,192 | -8.48% | 0.04% |
| CETERA INVESTMENT ADVISERS | 02/14/2025 | 13,100 | $26,200 | -7.53% | 0.04% |
| INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 12,653 | $25,306 | 100.00% | 0.04% |
| SKOPOS LABS, INC. | 01/15/2025 | 11,500 | $23,000 | 100.00% | 0.03% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 10,102 | $20,204 | -1.58% | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 10,061 | $20,122 | -3.85% | 0.03% |
| FMR LLC | 02/13/2025 | 6,238 | $12,476 | 95.43% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 4,624 | $9,248 | 11.21% | 0.01% |
| NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 2,900 | $6,000 | 0.00% | 0.01% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 2,816 | $5,632 | 0.00% | 0.01% |
| GROVE BANK & TRUST | 01/16/2025 | 1,000 | $2,000 | 0.00% | 0.00% |
| AMALGAMATED BANK | 02/04/2025 | 880 | $2,000 | 0.00% | 0.00% |
| FEDERATED HERMES, INC. | 02/13/2025 | 607 | $1,214 | 100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 01/30/2025 | 261 | $441 | 0.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 40 | $80 | 122.22% | 0.00% |
| STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 26 | $52 | 0.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SYMPHONY FINANCIAL, LTD. CO. | 01/24/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
FibroBiologics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of FibroBiologics, Inc. Common Stock. The most heavily invested institutionals were:
BlackRock, Inc.: 1.79 M
GEODE CAPITAL MANAGEMENT, LLC: 604,927
Cascade Financial Partners, LLC: 282,601
NORTHERN TRUST CORP: 215,413
Requisite Capital Management, LLC: 109,713
BANK OF AMERICA CORP /DE/: 89,852
16.01% of FibroBiologics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 4.72 M shares in the last 24 months. This purchase volume represents approximately $4.20 M in transactions.